<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <p content-type="self-citation">
  <mixed-citation publication-type="self-citation" id="rmv2163-cit-9001">
   <string-name>
    <surname>Oliver</surname>
    <given-names>ME</given-names>
   </string-name>, 
   <string-name>
    <surname>Hinks</surname>
    <given-names>TSC</given-names>
   </string-name>. 
   <article-title>Azithromycin in viral infections</article-title>. 
   <source xml:lang="en">Rev Med Virol</source>. 
   <year>2020</year>;
   <elocation-id>e2163</elocation-id>
   <pub-id pub-id-type="doi">10.1002/rmv.2163</pub-id>
   <pub-id pub-id-type="pmid">32969125</pub-id>
  </mixed-citation>
 </p>
 <fn-group>
  <fn id="rmv2163-note-1002">
   <p>
    <bold>Funding information</bold> University of Oxford, Grant/Award Number: University of Oxford COVID‚Äê19 Research Response Fund; Wellcome Trust, Grant/Award Numbers: 211050/Z/18/A, 211050/Z/18/z; Pfizer; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)
   </p>
  </fn>
 </fn-group>
</notes>
